Liquidia Corp (LQDA)
13.35
+0.64
(+5.04%)
USD |
NASDAQ |
May 20, 16:00
13.36
0.00 (0.00%)
After-Hours: 20:00
Liquidia Shareholders Equity (Quarterly): 86.26M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 86.26M |
December 31, 2023 | 47.29M |
September 30, 2023 | 48.01M |
June 30, 2023 | 60.66M |
March 31, 2023 | 81.64M |
December 31, 2022 | 90.42M |
September 30, 2022 | 95.03M |
June 30, 2022 | 102.11M |
March 31, 2022 | 55.39M |
December 31, 2021 | 65.26M |
September 30, 2021 | 72.96M |
June 30, 2021 | 79.02M |
March 31, 2021 | 62.91M |
Date | Value |
---|---|
December 31, 2020 | 71.09M |
September 30, 2020 | 65.28M |
June 30, 2020 | 8.870M |
March 31, 2020 | 21.77M |
December 31, 2019 | 34.95M |
September 30, 2019 | 19.55M |
June 30, 2019 | 32.09M |
March 31, 2019 | 37.32M |
December 31, 2018 | 18.69M |
September 30, 2018 | 27.86M |
June 30, 2018 | -12.91M |
March 31, 2018 | -4.010M |
December 31, 2017 | -33.69M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.870M
Minimum
Jun 2020
102.11M
Maximum
Jun 2022
60.03M
Average
64.09M
Median
Shareholders Equity (Quarterly) Benchmarks
United Therapeutics Corp | 5.338B |
AIM ImmunoTech Inc | 4.826M |
Perspective Therapeutics Inc | 229.89M |
Protalix BioTherapeutics Inc | 29.79M |
Armata Pharmaceuticals Inc | -56.51M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 197.12M |
Total Liabilities (Quarterly) | 110.86M |
Current Ratio | 7.660 |
Net Debt Paydown Yield | 0.35% |